• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    W
    Wanbury Ltd.
    27 Jun 2025
    250.25
    -3.23%
    This pharma co's stock rose on launching iron supplement to treat anemia
    Business Standard
    Wanbury share price climbed 2.4 per cent after the company launched iron supplement 'Wanbury C RED'
    Copy LinkShare onShare on Share on Share on
    Wanbury Ltd. is trading below all available SMAs
    logo
    AstraZeneca Pharma India Ltd.
    26 Jun 2025
    8934.50
    -1.54%
    AstraZeneca expands Bengaluru global hub with 166-cr investment
    Business Line
    This is AstraZeneca's second major investment in India within a year after the expansion of its Global Innovation and Technology Centre (GITC) in Chennai
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    AstraZeneca Sets Up Rs 166 Crore Global Hub To Boost AI Driven Healthcare
    NDTV Profit | 26 Jun 2025 1 more
    AstraZeneca sets up 166 cr Global Hub to boost AI driven healthcare
    Business Standard | 26 Jun 2025
    logo
    Lupin Ltd.
    26 Jun 2025
    2055.60
    0.44%
    Lupin launches generic chronic constipation treatment drug in US
    Business Line
    The company has launched Prucalopride tablets of strengths 1 mg and 2 mg in the US, following the recent approval of its abbreviated new drug application (ANDA) from the USFDA
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading above all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    26 Jun 2025
    1321.70
    -0.08%
    Dr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth Concerns
    Dr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth Concerns
    NDTV Profit
    Citi expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch of generic Semaglutide.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    logo
    Cipla Ltd.
    26 Jun 2025
    1575.80
    -0.15%
    Cipla Dividend: Last Day To Buy Shares To Qualify Details Here
    Cipla Dividend: Last Day To Buy Shares To Qualify Details Here
    NDTV Profit
    Cipla's board announced a final dividend of Rs 13 per share and a special dividend of Rs 3 for financial year 2025.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    logo
    Glenmark Pharmaceuticals Ltd.
    25 Jun 2025
    2085.20
    -1.10%
    Glenmark Pharmaceuticals shares up 3% on launching cancer drug Tevimbra
    Business Standard
    Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in India, following approval by the Central Drugs Standard Control Organisation.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuti.. has an average target of 2144.00 from 5 brokers.
    Glenmark Pharma Launches Lung Cancer Treatment Drug After Approval From Authorities
    NDTV Profit | 24 Jun 2025 1 more
    Glenmark Pharma launches lung cancer treatment drug Tevimbra in India
    Business Standard | 24 Jun 2025
    logo
    Influx Healthtech Ltd.
    25 Jun 2025
    192.00
    0.31%
    Influx Healthtech lists at 38% premium on NSE SME, beats GMP estimates
    Business Standard
    After the listing, shares of Influx Healthtech were trading at 127.5, down 3.77 per cent from the opening price
    Copy LinkShare onShare on Share on Share on
    Influx Healthtech Ltd. has gained 100.00% in the last 6 Months
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    24 Jun 2025
    1714.20
    1.38%
    JB Chemicals Receives USFDA Approval For Drug That Treats Depression Symptoms
    JB Chemicals Receives USFDA Approval For Drug That Treats Depression Symptoms
    NDTV Profit
    The USFDA granted JB Chemicals approval for its new drug application, Amitriptyline Hydrochloride Tablets United States Pharmacopeia.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 319 to 311 in Jun 2025 qtr
    logo
    Aurobindo Pharma Ltd.
    24 Jun 2025
    1119.20
    -0.86%
    Aurobindo Pharma Arm CuraTeQ Receives UK Approval For Dyrupeg Drug
    Aurobindo Pharma Arm CuraTeQ Receives UK Approval For Dyrupeg Drug
    NDTV Profit
    The drug Dyrupeg is used to help cancer patients with neutropenia, which is a low level of a type of white blood cell.
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
    logo
    Gland Pharma Ltd.
    24 Jun 2025
    2022.80
    0.31%
    Gland Pharma jumps 3% in trade; here's what is boosting investor interest
    Business Standard
    Gland Pharma share price rose 3 per cent logging an intraday high at 1,800 per share; here's why
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. is trading above all available SMAs
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd